Abiopharma

🔍 Roewe Randall Allen (Executive)

Company: FIRST FINANCIAL BANKSHARES INC (FFIN)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 1,984 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: false | shares_owned_after: 35,299.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,100 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: D | equity_swap_involved: false | shares_owned_after: 34,199.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 564 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: D | equity_swap_involved: false | shares_owned_after: 33,635.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 3,684 shares of Employee Stock Option, Right to Buy at $35.28 per share (Derivative)
  Date: 2026-08-14 | Code: A | Expires: 2036-08-14 | equity_swap_involved: false | shares_owned_after: 3,684.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 1,100 shares of Deferred Stock Units (Derivative)
  Date: 2026-08-14 | Code: A | equity_swap_involved: false | shares_owned_after: 7,396.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 564 shares of Deferred Stock Units (Derivative)
  Date: 2026-08-16 | Code: A | equity_swap_involved: false | shares_owned_after: 7,960.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3

Footnotes:

• F1: Reflects grant of restricted stock units (RSUs) which vest in three approximately equal installments on each of the three anniversaries of the grant date.
• F2: In connection with the vesting on August 14, 2026, of 1,100 restricted stock units previously granted to the reporting person, the reporting person's receipt of 1,100 shares of common stock was deferred resulting in the reporting person's receipt instead of 1,100 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 1,100 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.
• F3: In connection with the vesting on August 16, 2026, of 564 restricted stock units previously granted to the reporting person, the reporting person's receipt of 564 shares of common stock was deferred resulting in the reporting person's receipt instead of 564 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 564 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.
• F4: The options vest 33.33% after one year from the grant date, 66.66% after the second year, and 100% after the third year.